Table 4.
Potential predictors for CD grade ≥2 complications, logistic regression analyses
| Variable | Univariate |
Multivariate |
||
|---|---|---|---|---|
| p value | OR (95% CI) | p value | OR (95% CI) | |
| Age | 0.137 | 1.025 (0.992–1.058) | − | − |
| ASA score | 0.001 | 2.112 (1.359–3.281) | 0.002 | 2.042 (1.306–3.195) |
| P-Bx <8 weeks before HoLEP | 0.780 | 1.127 (0.489–2.597) | − | − |
| Anticoagulation/antiplatelet Tx | 0.060 | 1.660 (0.979–2.816) | − | − |
| Transurethral catheter | 0.030 | 1.821 (1.059–3.131) | − | − |
| UTI | 0.096 | 1.574 (0.923–2.683) | − | − |
| Prostate volume | 0.903 | 1.000 (0.994–1.007) | − | − |
| Prostate cancer Surgeon (Ref. surgeon 1) | 0.015 | 2.153 (1.159–4.000) | 0.038 | 1.940 (1.036–3.633) |
| Surgeon 2 | 0.315 | 0.729 (0.393–1.352) | − | − |
| Surgeon 3 | 0.845 | 1.070 (0.541–2.116) | − | − |
| Caseload (ref. >120) | ||||
| 0–40 | 0.443 | 1.326 (0.645–2.723) | − | − |
| 40–80 | 0.231 | 0.554 (0.211–1.456) | − | − |
| 80–120 | 0.847 | 0.924 (0.413–2.065) | − | − |
| HES | 0.872 | 1.000 (0.997–1.003) | ||
Bold values indicate p values <0.05. CD, Clavien-Dindo; P-Bx, prostate biopsy; UTI, urinary tract infection; Tx, therapy; Ref., reference; OR, odds ratio; 95% CI, 95% confidence interval; HES, HoLEP efficiency score; HoLEP, holmium laser enucleation of the prostate; ASA, American Society of Anesthesiologists.